KD025

€89.00

Excl. VAT

Item no.	TMO-T6867-10mg
Manufacturer	TargetMol
CASRN	911417-87-3
Amount	10mg
Category	Oncology Reagents & Chemicals Molecules By Organ Hepatic Cancer
Type	Molecules
Specific against	other
Citations	1. Lee JH, et al. Ann Clin Transl Neurol. 2014, 1(1), 2-14.
Smiles	CC(C)NC(=O)COc1cccc(c1)-c1nc(Nc2ccc3[nH]ncc3c2)c2ccccc2n1
ECLASS 10.1	32169090
ECLASS 11.0	32169090
UNSPSC	12000000
Alias	ROCK inhibitor, Rezurock , SLx-2119 , KD025 , ROCK inhibitor
Available
Short Description	KD025 is an orally available, and specific ROCK2 inhibitor (IC50/Ki: 60/41 nM).
Shipping	cool pack
Storage	-20°
Target names or alias	Rezurock , SLx-2119 , KD025 , ROCK inhibitor
Molecular Weight	452, 51
Pathway	Cell Cycle/Checkpoint\|\|\|Stem Cells\|\|\|Cytoskeletal Signaling
Target	ROCK

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 10mg

Listprice: €89.00

Price: €89.00

available

Delivery expected until 8/21/2025

Quantity:

Compare